Search Results - Johan Blakkisrud

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Radionuclides for Targeted Therapy: Physical Properties

    Radionuclides for Targeted Therapy: Physical Properties by Caroline Stokke, Monika Kvassheim, Johan Blakkisrud

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [<sup>177</sup>Lu]Lu-DOTATATE

    SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [<sup>177</sup>Lu]Lu-DOTATATE by Johan Blakkisrud, Avery Peterson, S.J. Wildermann, Griffen Kingkiner, Ka Kit Wong, Chang Wang, Kirk A. Frey, Caroline Stokke, Yuni K. Dewaraja

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials

    EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials by Caroline Stokke, Silvano Gnesin, Johannes Tran‐Gia, Francesco Cicone, Søren Holm, Marta Cremonesi, Johan Blakkisrud, Thomas Wendler, Nic Gillings, Ken Herrmann, Felix M. Mottaghy, Jonathan Gear

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

    Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma by Arne Kolstad, Tim Illidge, Nils Bolstad, Signe Spetalen, Ulf Madsbu, Caroline Stokke, Johan Blakkisrud, Ayca Muftuler Løndalen, N. O’Rourke, Matthew Beasley, Wojciech Jurczak, Unn‐Merete Fagerli, Michal Kaščák, M. Bayne, Aleš Obr, Jostein Dahle, Lisa Rojkjaer, Véronique Pascal, Harald Holte

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: